News
Vektor Medical Presents AI-Powered Research at HRX 2024
Vektor's Chief Technology Officer, Chris Villongco, will present two studies at HRX 2024, showcasing the innovative use of AI in analyzing wall thickness and scar tissue in ventricular tachycardia patients. These studies, selected for the Top 5 AbstracX session, demonstrate Vektor’s cutting-edge approach to improving VT treatment.
The first study highlights the integration of vMap’s AI-driven ECG analysis with CT data for precise localization of VT sources, optimizing ablation procedures. The second study validates the accuracy of Vektor’s AI models in analyzing myocardial wall thickness, further enhancing VT care.
Vektor Medical, Inc. Successfully Closes Its Convertible Note Funding Round
Today, Vektor Medical, Inc. announces the closing of its Convertible Note funding round. The funds will be used to support research relating to and development of a non-invasive computational arrhythmia mapping device. “We’re excited to welcome our investors on board and join Vektor’s journey in creating the next generation of arrhythmia mapping technology. This funding round enables us to build out our team and further research and develop the technology created by our UCSD founders”. Mike Monko, CEO & Co-Founder of Vektor Medical, Inc.